- Pear collaborates with Empatica, etectRx and KeyWise to bolster its PDT platform with digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics
- The new technologies complement its voice-based biomarkers previously licensed from Winterlight. The licensed technologies will facilitate the building of products for patients’ physiologic sensing
- Pear’s physiologic sensing portfolio allows personalizing products in real-time and pharmaceutical dosing, thus providing an opportunity for enhanced patient outcomes across a wide range of disease states
Click here to read full press release/ article | Ref: Pear Therapeutics | Image: PMLive
The post Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform first appeared on PharmaShots.